What Is BPC-157 + TB-500? Research Evidence & Profile

What Is BPC-157 + TB-500?

BPC-157 + TB-500 Blend is a two-component peptide blend identified by the BPC-157 and TB-500 names supplied in the catalogue. This page identifies the material as BPC-157 + TB-500 Blend, with amino acid count BPC-157: 15 TB-500: 7; synonyms BPC-157 + TB-500 blend. The BPC-157 + TB-500 Blend identifiers distinguish this catalogue entry from similarly named compounds, fragments, modified analogues, and multi-component formulations.

This is a multi-component catalogue blend, so a single molecular formula, molecular weight or CAS number is not assigned to the combined product.

Evidence at a Glance

0ClinicalTrials.gov query records

0PubMed query records

0Selected publications shown

Sources: ClinicalTrials.gov query · PubMed query · Retrieved 2026-10-06

Mechanism & Pharmacology

The research record for BPC-157 + TB-500 Blend is organized around blend identity review, component comparison, peptide characterization, and analytical workflow development. For BPC-157 + TB-500 Blend, those subjects define the literature and analytical context of this specific research peptide; they do not establish a clinical indication, administration route, or expected outcome.

Mechanistic or pathway language defines a research scope. It does not establish that a catalogue product produces a clinical effect.

Clinical Development

Selected exact-query registry records are shown below. Desktop displays up to six; mobile displays up to three.

NCT ID / Study	Phase	Status	Context	Last registry update
No exact-match registry records were returned by the displayed query at the retrieval time.

Source: ClinicalTrials.gov search · Retrieved 2026-10-06

Selected Literature0 important records shown

Selected Literature

No exact-match PubMed records were selected by the displayed query at the retrieval time.

Source: PubMed search results · Retrieved 2026-10-06

Identity & ChemistryProduct-form fields

Identity & Chemistry

Compound / Blend: BPC-157 + TB-500 Blend
Available Specifications: 10mg, 20mg
Pack Format: 10 Vials
CAS Number: BPC-157: 137525-51-0 TB-500: 885340-08-9
Molecular Formula: BPC-157: C62H98N16O22 TB-500: C38H68N10O14
Molecular Weight: BPC-157: 1419.55 TB-500: 889.02
Amino Acid Count: BPC-157: 15 TB-500: 7
Sequence: BPC-157: Gly-Glu-Pro-Pro-Pro-Gly-Lys-Pro-Ala-Asp-Asp-Ala-Gly-Leu-Val TB-500: Ac-Leu-Lys-Lys-Thr-Glu-Thr-Gln-OH
Synonyms: BPC-157 + TB-500 blend
Physical Form: Lyophilized powder

This is a multi-component catalogue blend, so a single molecular formula, molecular weight or CAS number is not assigned to the combined product.

Source: NOVABIO product identity record · No single PubChem record is asserted for this catalogue entry.

Research Tools for BPC-157 + TB-500

Review the selected registry records and open the module-level ClinicalTrials.gov query for the current result set.

Open Clinical Development

Use the complete NOVABIO documentation library to review currently available batch records.

Open Lab Results & COA

Storage & Laboratory HandlingDocumentation-led controls

Storage & Laboratory Handling

Confirm the exact material form, lot, supplied state and storage statement from the product label and corresponding batch documentation. Do not infer handling conditions from a different compound, strength or external clinical publication.

Regulatory Status

FDA status must be checked by exact drug product, formulation and indication; catalogue availability does not establish approval.

Source: FDA Drugs@FDA · Checked 2026-10-06

Authoritative Data Summary

BPC-157 + TB-500 Research Summary

Identity

BPC-157 + TB-500 Blend; specifications: 10mg, 20mg. This is a multi-component catalogue blend, so a single molecular formula, molecular weight or CAS number is not assigned to the combined product.

Mechanism

Evidence

0 registry records and 0 PubMed records were returned by the displayed query on 2026-10-06; counts are not quality ratings.

Regulatory context

FDA status must be checked by exact drug product, formulation and indication; catalogue availability does not establish approval.

BPC-157 + TB-500 is represented here by the catalogue identity BPC-157 + TB-500 Blend. This is a multi-component catalogue blend, so a single molecular formula, molecular weight or CAS number is not assigned to the combined product. The product record lists 10mg, 20mg as the currently available specifications. The research context is organized around this product-specific scope: The research record for BPC-157 + TB-500 Blend is organized around blend identity review, component comparison, peptide characterization, and analytical workflow development. For BPC-157 + TB-500 Blend, those subjects define the literature and analytical context of this specific research peptide; they do not establish a clinical indication, administration route, or expected outcome. The synchronized searches returned 0 ClinicalTrials.gov records and 0 PubMed records for the displayed query. A registry count includes records with different designs, statuses and populations, while a publication count can include reviews, preclinical work and unrelated uses of a shared abbreviation; neither count is a quality score. For regulatory interpretation, FDA status must be checked by exact drug product, formulation and indication; catalogue availability does not establish approval. Clinical findings apply only to the studied drug product, formulation, population and protocol. NOVABIO product specifications and batch documentation are separate catalogue records and do not inherit clinical outcomes from external studies. This profile supports identity checking, source tracing and laboratory record review; it does not certify a batch, recommend treatment, provide dosing instructions or replace current official labeling and professional judgment.

Sources: PubMed · ClinicalTrials.gov · FDA · NOVABIO product record

FAQ4 evidence-bounded answers

BPC-157 + TB-500 FAQ

What is BPC-157 + TB-500?

What research records are indexed for BPC-157 + TB-500?

The synchronized query returned 0 ClinicalTrials.gov records and 0 PubMed records on 2026-10-06; review the linked searches because counts and record status can change.

Is BPC-157 + TB-500 FDA approved?

FDA status must be checked by exact drug product, formulation and indication; catalogue availability does not establish approval.

Does this page provide dosing guidance?

No. This research profile provides identity, evidence, chemistry, regulatory and documentation context without dosing or treatment instructions.

Sources, Methodology & Last Verified

Official sources: ClinicalTrials.gov, NCBI PubMed, FDA, available PubChem records, and NOVABIO product and COA records.
Query retrieved: 2026-10-06T12:08:49Z
Inclusion: Exact identity terms and traceable registry, publication, chemistry, regulatory or catalogue fields.
Limitations: Search counts can include mixed evidence types and shared-name records; individual records require direct review.
Prepared by: NOVABIO Research
Reviewed date: 2026-10-06
Editorial methodology: How NOVABIO builds Research Profiles
Corrections contact: Contact NOVABIO with the page URL and source record.